Tasly Pharmaceutical Group Co., Ltd

SSE 600535 Stock
Yield per half year: -1.56%
Dividend yield: 0%
Sector: Healthcare

Fair price Tasly Pharmaceutical Group Co., Ltd

Current price
15.18 Β₯
Average price
10.47 Β₯ -31%
Price based on EPS
6.75 Β₯ -55.56%
Price according to DCF model (FCF)
23.01 Β₯ +51.56%
Discount price Net Income
9.43 Β₯ -37.88%
2.5/10

Price based on EPS

Price = EPS * (1 + CAGR EPS) / (Key Rate * Excess Key Rate)
Key Rate = Key rate
Fair price = 6.75 Β₯
Current price = 15.18 Β₯ (difference = -55.56%)


Data

Discounted Cash Flow (Based EBITDA)

Price = (Terminal Value + Company Value) / Count shares
Price - Fair price
Terminal Value β€” cost in the post-forecast period
Company Value β€” cost during the forecast period
Count shares - Number of shares
Terminal Value = Discount Ebitda(5) * (1 + Ebitda Yield) / (WACC - Ebitda Yield)
Company Value = βˆ‘ (Future Ebitda / (1 + WACC) ^ 5)
WACC - weighted average cost of capital (taking into account country risks, inflation, taxes, etc.)
Fair price = 2.72 Β₯
Current price = 15.18 Β₯ (difference = -82.1%)


Data

Discounted Cash Flow (Based FCF)

Price = (Terminal Value + Company Value) / Count shares
Price - Fair price
Terminal Value β€” cost in the post-forecast period
Company Value β€” cost during the forecast period
Count shares - Number of shares
Terminal Value = Discount FCF(5) * (1 + FCF Yield) / (WACC - FCF Yield) ^ 5
Company Value = βˆ‘ (FCF / (1 + WACC) ^ 5)
WACC - weighted average cost of capital (taking into account country risks, inflation, taxes, etc.)
Fair price = 23.01 Β₯
Current price = 15.18 Β₯ (difference = +51.56%)


Data

Pay for your subscription

More functionality and data for company and portfolio analysis is available by subscription

Subscribe